Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,425 | 3,692 | 5,640 | 8,898 | 9,171 |
| Marketable Securities | 81,456 | 2,021 | 7,210 | 11,863 | 21,230 |
| Receivables | 560 | N/A | 21 | 55 | 97 |
| TOTAL | $113,277 | $9,308 | $16,297 | $23,792 | $32,537 |
| Non-Current Assets | |||||
| PPE Net | 13,114 | 13,858 | 14,611 | 15,368 | 16,077 |
| Investments And Advances | 50,609 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 6,449 | 6,963 | 7,213 | 5,035 | 5,184 |
| TOTAL | $70,172 | $20,821 | $21,823 | $20,403 | $21,260 |
| Total Assets | $183,448 | $30,130 | $38,120 | $44,196 | $53,797 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,955 | 2,622 | 2,520 | 1,695 | 1,297 |
| Accrued Expenses | 6,850 | 7,092 | 6,056 | 5,473 | 6,880 |
| TOTAL | $10,793 | $10,677 | $9,653 | $7,980 | $8,816 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 115 |
| Other Non-Current Liabilities | 4,419 | 4,236 | 3,821 | 6,970 | 4,766 |
| TOTAL | $7,581 | $7,436 | $7,059 | $10,246 | $8,078 |
| Total Liabilities | $18,374 | $18,113 | $16,713 | $18,226 | $16,895 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,607 | 10,411 | 9,292 | 9,289 | 9,229 |
| Common Shares | 5 | 1 | 1 | 1 | 1 |
| Retained earnings | -94,034 | -139,480 | -129,366 | -124,169 | -112,774 |
| Other shareholders' equity | 550 | 463 | 367 | 344 | 531 |
| TOTAL | $165,074 | $12,016 | $21,408 | $25,970 | $36,903 |
| Total Liabilities And Equity | $183,448 | $30,130 | $38,120 | $44,196 | $53,797 |